English
繁體中文
简体中文
日本語
4th In-Vitro 2D & 3D Neuronal Networks Summit
MxW Summit 2024
8 – 10 April 2024 | Zurich, Switzerland
Join us at the 4th In-Vitro 2D & 3D Neuronal Networks Summit, on April 8-10, in Zurich!
This summit is a pivotal event for the neuroscience community, showcasing the latest research in iPSC-derived neurons, neural organoids, and the applications of microelectrode arrays (MEAs). The event is open to all interested in neuroscience, cell biology, drug discovery, disease modeling, and bio/neuroengineering to exchange knowledge and drive progress in these fields.
The program includes scientific talks and presentations from keynote, invited speakers and short talks from selected abstracts, featuring leading experts who will share their insights and discoveries. Poster sessions and social activities are also part of the MxW Summit 2024 highlights, offering more opportunities for scientific dialogue and networking.
We are excited to have you join us in Zurich for the 4th In-Vitro 2D & 3D Neuronal Networks Summit!
Explore why attendees from last year’s edition highly recommend the Summit!
Confirmed Keynote Speakers:
Prof. Dr. Cedric Bardy
South Australian Health and Medical Research Institute (SAHMRI)
Australia
Prof. Dr. Feng Guo
Indiana University Bloomington
USA
Prof. Dr. Nako Nakatsuka
Neuro-X Institute, École Polytechnique Fédérale de Lausanne (EPFL)
Switzerland
Prof. Dr. Tom Nowakowski
University of California San Francisco (UCSF)
USA
Prof. Dr. Magdalini Polymenidou
University of Zurich (UZH)
Switzerland
Special Invited Speaker
Prof. Dr. Hirokazu Takahashi
The University of Tokyo
Japan
Scientific Topics:
Neural Stem Cells and Organoids
Brain Development
Brain Microcircuit Function and Dysfunction
Disease Modeling and Drug Discovery
Controlled Neural Networks
Cutting-Edge Neurotechnologies
Advanced Electrophysiology Techniques
Computational Neuroscience
Find all the details below:
Our sponsors:
Gold Sponsors
bit.bio combines the concepts of cell programming and biology to provide human cells for research, drug discovery and cell therapy, enabling a new generation of medicines. This is possible with our precision human cellular reprogramming technology opti-oxTM – a gene engineering approach that enables unlimited batches of any human cell to be manufactured consistently at scale.
Neuroservices-Alliance (NsA) is renowned worldwide as a leader in electrophysiology services for preclinical CNS and Pain drug discovery. NsA equips the pharmaceutical industry with functional readouts to inform neuro-pharmacological decisions. Data is generated from complementary platforms: in vitro cell and brain slice electrophysiology; and in vivo brain and spinal cord electrophysiology. NsA’s integrated functional data from rodent and human tissues enable fast and robust lead selection and optimization, investigation of the mechanism of action (MOA), and validation of target engagement. NsA employs the MaxTwo HD-MEA to electrophysiologically characterize iPSC-derived neurons, disease models, and DRG sensory neuron cultures.
Registrations Closed:
Regular Registration Fees
Registration until April 1st
- Student: 225 CHF
- Academic: 335 CHF
- Industry: 440 CHF
Other Fees:
- Social Activity (Monday Evening): No Additional Cost
- Dinner (Tuesday Evening): 55 CHF